Ulnar Collateral Ligament Tears in Adolescent Baseball Pitchers: A Scoping Review with Pooled Risk Factor Analysis and Comparison of Surgical Outcomes

Asim Handy^*

University of Pennsylvania, Philadelphia, Pennsylvania, PA 19104, USA

^*Corresponding Author: Asim Handy, University of Pennsylvania, Philadelphia, Pennsylvania, PA 19104, USA.

Received: 29 March 2026; Accepted: 07 July 2026; Published: 16 July 2026

1. Introduction

Ulnar collateral ligament tears of the medial elbow are among the most consequential injuries in all of competitive baseball [1]. The anterior bundle of the UCL is the primary restraint against the valgus torque generated during the late cocking and acceleration phases of the pitching motion [2]. Biomechanical analyses demonstrate that professional pitchers experience loads approaching 64 Newton-meters at the elbow with each pitch thrown at competitive velocity, a force that exceeds the estimated ultimate tensile strength of the UCL at approximately 32 Newton-meters [3]. The structural mismatch between applied valgus force and native ligament strength is managed acutely through dynamic stabilization provided by the flexor-pronator and triceps muscles chronically through adaptation from the ligament that continues until the cumulative burden of microtraumatic loading exceeds the capacity for self-repair between pitching appearances [4].

What was once regarded predominantly as a professional athlete injury has been transformed into a pediatric sports medicine crisis of considerable magnitude. Between 1994 and 2008 the proportion of UCL reconstructions performed at the American Sports Medicine Institute on high school-aged or younger athletes rose from 7% to 26% and by 2019 youth and high school pitchers aged 19 years and younger constituted approximately half of all UCL reconstructions performed at leading centers nationally [1,5]. The 15 to 19 year age group now carries the highest annual UCL reconstruction incidence of any demographic in the United States, which represents a complete inversion of the historical pattern in which professional athletes dominated the operative caseload [5,6], and national database analyses confirm that the rate of increase in this age group has outpaced every other demographic over the past two decades [1].

This demographic transformation is attributable to a convergence of economic and cultural forces that have fundamentally restructured youth baseball over the preceding three decades. The explosive growth of year-round travel and tournament baseball has created a pitching exposure environment that substantially exceeds what prior generations of adolescents experienced. High-stakes showcase events that reward radar-gun velocity above all other measurable attributes create systematic incentives for maximal-effort throwing at developmentally vulnerable ages [3,7,8]. The primacy of peak fastball velocity as the dominant draft evaluation metric reinforces these incentives at every level of the amateur baseball pipeline. It has been demonstrated that pitchers who achieved elite velocity thresholds at younger ages and attended a higher volume of showcases before skeletal maturity underwent UCL reconstruction significantly earlier and suffered substantially worse long-term career outcomes than those who achieved the same velocity at later ages [7,8].

Despite the urgency and scope of this problem, UCL based literature specific to adolescent throwers remains fragmented in ways that complicate evidence-based clinical management. Risk factor studies have largely examined mixed-age cohorts in which the adolescent subgroup represents a minority without independent stratified analysis [9,10]. MRI-based morphological characterization specific to the adolescent UCL tear pattern has been reported in only a single published series [11]. Also, surgical outcome data are dominated by professional athlete registries that differ meaningfully from high school pitchers in tissue and ligament structure and the socioeconomic motivation to accelerate return to play [12,13]. This comprehensive scoping review was designed to address that gap by integrating the best available evidence across all relevant domains into a format that is directly useful to the clinicians, athletic trainers, coaches and policymakers responsible for the health of adolescent pitchers.

2. Methods

2.1 Search Strategy

A systematic search of PubMed and MEDLINE was conducted using the following MeSH terms and free-text keywords in Boolean combination: "ulnar collateral ligament" AND ("baseball" OR "pitcher" OR "throwing athlete") AND ("adolescent" OR "youth" OR "high school" OR "pediatric" OR "young athlete"). Secondary search terms included Tommy John surgery, UCL reconstruction, risk factors, pitch count, overuse injury, elbow biomechanics and return to play. The search date range was January 2002 through March 2026 restricted to English-language publications. Reference lists of all included studies were hand-searched to identify additional eligible citations not captured by the primary database query.

2.2 Inclusion and Exclusion Criteria

Studies were included when they reported primary data on UCL injury, reconstruction or associated risk factors in baseball pitchers and enrolled adolescent participants or reported stratified data for athletes 19 years of age or younger and reported quantitative outcomes including injury incidence, odds ratios, surgical outcomes or pitch count associations and were published in peer-reviewed journals indexed in PubMed. Studies were excluded when they consisted of case reports with fewer than five subjects or biomechanical cadaveric studies without clinical outcomes or studies reporting exclusively on professional athletes without any adolescent-specific analysis or stratified subgroup data.

2.3 Data Extraction and Quality Assessment

Data were extracted independently from the full text of each included study and verified against primary source tables, figures and abstracts. Level of evidence was assigned using the Oxford Centre for Evidence-Based Medicine hierarchy. For the pooled risk factor synthesis presented in Table 2 effect estimates were taken from adjusted analyses when available and unadjusted estimates were used with explicit notation where adjusted data were not reported. Studies with mixed-age populations were included when they reported UCL-specific outcomes reasonably attributable to the adolescent subgroup based on the age distribution of enrolled participants.

3. Results

3.1 Included Studies

Eighteen studies met final inclusion criteria encompassing more than 40,000 participants across two prospective cohorts [9,10], five retrospective cohort studies [3,5-8,13], four retrospective case series [12,14-16], three systematic reviews or meta-analyses [4,17,18], three cross-sectional studies [11,19] and one national database analysis [1], all organized by thematic domain in Table 1 and spanning the epidemiology, risk factor, surgical outcomes, nonoperative management and prevention literature from 2002 through 2023.

Table 1: Scoping Review: UCL Tears in Adolescent Baseball Pitchers: Included Studies (N=18; 2002 to 2023).

3.2 Pooled Risk Factor Analysis

Table 2 presents a pooled synthesis of quantified risk factor estimates derived from included studies. Effect sizes are reported as published in primary sources and where multiple studies examined the same exposure the most methodologically rigorous estimate is presented. All citation numbers in Table 2 correspond directly to the reference list below and to the same citations used throughout the text.

Table 2: Pooled Risk Factor Summary: Quantified Associations with UCL Injury and UCL Reconstruction in Adolescent Baseball Pitchers.

3.3 Surgical and Nonoperative Outcomes

Table 3 compares return-to-play rates, time to return and complication rates across the major UCL reconstruction technique series, registry studies and nonoperative management studies organized by treatment category, and all return-to-play rates reflect return to the same or a higher level of competition unless explicitly noted otherwise. Citation numbers in Table 3 correspond to the same references cited in the text.

Table 3: Surgical and Nonoperative Outcomes for UCL Injuries in Adolescent and Young Baseball Pitchers: Technique Comparison.

4. Discussion

4.1 Epidemiologic Trajectory

National database analyses consistently confirm that the 15 to 19 year age group now carries the highest annual UCL reconstruction incidence of any demographic, a finding replicated independently across the PearlDiver, MarketScan and ASMI institutional registries. The pace of this increase has not shown meaningful deceleration through the most recent surveillance period [1,5,6]. There is a documented national UCL-R incidence of 3.96 per 100,000 with adolescent males representing the dominant and fastest-growing contributor to surgical volume [5,20]. Geographic disparities demonstrate significantly higher rates in warm-climate southern states providing strong indirect evidence for year-round throwing exposure as the primary structural driver of regional variation. The trend can be confirmed upward through the professional pipeline given that 25% of all active MLB pitchers have already undergone UCL reconstruction in their careers and the mean age at first surgery has been declining measurably across successive cohort decades [6]. The finding that UCL injuries and surgeries cluster in March through May provides an actionable prevention insight attributable to the convergence of reduced glenohumeral external rotation accumulated over the offseason and abrupt workload escalation at season onset. Preseason range-of-motion restoration protocols combined with progressive pitch volume ramp-up schedules represent underutilized low-cost prevention opportunities [13].

4.2 Workload as the Dominant Modifiable Risk Factor

The most consistent finding across all included studies is that pitching workload as measured by pitches per game, pitches per season and months of competitive pitching per year is the primary modifiable driver of adolescent UCL injury reconstruction. Quantitative thresholds for safe exposure have been established with reasonable precision by two independent prospective cohorts. A 10-year prospective study demonstrated that pitching more than 100 innings per season conferred a 3.5-fold increased risk of requiring surgery (OR 3.5; p=.002) and that year-round pitching without a minimum 4-month rest period was independently associated with injury after multivariate adjustment [10]. These findings were anticipated by earlier demonstrations that each 10-pitch increment above baseline increases elbow pain risk by 6% and that exceeding 75 pitches per outing increases risk by fully 50% [9]. Despite this strong and longstanding evidence base codified in the Pitch Smart guidelines since 2014 national UCL reconstruction rates in adolescents continued rising through 2019 without meaningful deceleration. A meta-analytic finding of a 57% reduction in UCL injury odds with guideline adherence (OR 0.43; 95% CI 0.26 to 0.72) argues compellingly for mandatory regulatory enforcement rather than the voluntary compliance model that has characterized the current prevention landscape [4,18].

4.3 Velocity and Showcase Participation

Previous 2022 and 2023 cohort studies of elite high school pitchers drafted in MLB rounds one through five represent the most methodologically sophisticated investigation of how the contemporary showcase economy intersects with UCL injury risk in ways that extend well beyond the individual playing career [7,8]. Peak fastball velocity was the single strongest independent predictor of UCL reconstruction (aOR 1.19 per mph; 95% CI 1.02 to 1.39; p=.03) [7]. Pitchers who underwent early UCL reconstruction had attended nearly twice as many showcases as those with late reconstruction (5.38 versus 2.89; p=.02), while pitchers who achieved the 90-mph velocity threshold at younger ages underwent reconstruction earlier and sustained significantly worse long-term career outcomes including measurably lower career earnings even after controlling for potential confounders [8]. These findings collectively indicate that the showcase and travel ball ecosystem creates structural incentives that may be fundamentally incompatible with UCL health in the adolescent pitcher and that policy interventions targeting showcase frequency and mandatory rest intervals between pitching appearances represent prevention opportunities not yet adequately addressed by existing guidelines.

4.4 UCL Tear Morphology and Conservative Management

A 2022 MR arthrography-based characterization of 200 adolescent pitchers fills a critical evidence gap by demonstrating that the tear morphology patterns seen in adolescents differ meaningfully from those documented in professional adult series [11]. Humeral-sided high-grade partial tears represent more than 50% of adolescent cases in contrast to the complete ulnar-sided tears that predominate in professional pitcher series [11]. This morphologic predominance of partial tears in adolescents carries direct and immediate clinical implications for initial treatment decision-making because partial tears at Grade I and Grade II severity have substantially higher rates of successful nonoperative management than complete ligament ruptures. 74% of adolescent pitchers with partial UCL tears returned to full competitive throwing following PRP injection at a mean of just 12 weeks [14]. Some adolescent pitchers may benefit from time for biological healing, and lack the economic urgency of professional athletes and who face recovery timelines of 19 to 20 months from UCL reconstruction at their career stage. A minimum 3 to 6 month trial of activity modification, flexor-pronator rehabilitation and PRP injection should constitute the obligatory first-line approach for partial UCL tears documented on MR arthrography rather than be an optional alternative.

4.5 Surgical Outcomes and Age-Specific Considerations

UCL reconstruction using the docking technique achieves 83 to 92% return to prior level of play across the major published series [21]. An adolescent-specific series of 31 skeletally immature pitchers with a mean age of 16.8 years confirmed that the procedure is safe in young athletes with no cases of physeal arrest or growth plate disturbance were identified at follow-up [14]. Vitale’s systematic review of 16 studies established the technical superiority of the docking technique over the original Jobe figure-eight approach (92% versus 79% return to play; p<.05), which informs the technical recommendation as applicable to the adolescent population [17]. Three critical age-specific considerations substantially modify the risk-benefit analysis for UCL reconstruction in adolescent pitchers compared to adult professionals. Recovery following UCL reconstruction typically requires 12 to 18 months before return to competitive pitching, with substantial variability based on level of play and rehabilitation course. In athletes undergoing reconstruction early in their competitive careers, this prolonged recovery interval may overlap with critical periods of skill development and recruitment [8]. In professional cohorts, UCL reconstruction has been associated with measurable long-term career impacts, including reductions in performance metrics and, in some studies, lower career earnings even after adjustment for confounding variables [8]. And a 20% overall complication rate represents a clinically meaningful risk that must be weighed explicitly in shared decision-making with adolescent patients and their families [12].

4.6 The Emerging Role of UCL Repair

Primary UCL repair with or without suture tape internal brace augmentation has attracted substantial clinical interest as an alternative to reconstruction in selected patients who present with proximal or distal avulsion-type tears. Adequate residual ligament tissue quality on imaging and intraoperative assessment, with early published series suggesting return-to-sport timelines of 7 to 9 months compared to 12 to 15 months for formal reconstruction, represents a potentially transformative reduction in recovery duration [22]. This is particularly meaningful for adolescent pitchers whose developmental windows are highly time sensitive. The evidence base specific to adolescent pitchers remains limited to small retrospective case series and no prospective randomized comparative trial exists in this age group, and this represents the single highest-priority evidence gap in the current literature and the most important target for future investigation [23].

5. Limitations

Substantial heterogeneity in study design, population definition and outcomes reporting across included studies limits formal meta-analytic pooling beyond selected risk factor estimates and the effect estimates in Table 2 should be interpreted as the best available approximations rather than definitive pooled statistical estimates. The majority of higher-quality prospective evidence derives from mixed-age or adult-dominant populations and truly adolescent-specific data are predominantly retrospective or cross-sectional in design [9,10]. Publication bias toward surgical case series with favorable outcomes also likely overestimates the proportion of UCL injuries requiring operative intervention. Also, race, ethnicity, socioeconomic status and coaching quality are inadequately captured across included studies despite their likely importance as moderators of both showcase participation and year-round throwing exposure.

6. Conclusions

UCL tears in adolescent baseball pitchers are driven predominantly by quantifiable and modifiable workload and velocity exposures that are amenable to intervention at every level of the youth baseball ecosystem and the synthesized evidence from this scoping review supports five principal conclusions:

1. Strict enforcement of evidence-based pitch count with seasonal rest guidelines including no more than 75 to 100 pitches per game by age group and a minimum of 4 months rest per year. No more than 100 innings per season represents the highest-yield prevention intervention currently available in the literature. This guideline adherence reduces UCL injury odds by 57% (OR 0.43; 95% CI 0.26 to 0.72) in published meta-analyses [18]. Voluntary compliance has demonstrably failed to decelerate the rising incidence in adolescents over two decades of guideline availability [1,4].
2. Showcase participation before musculoskeletal maturity should be paced and systematically restricted because peak fastball velocity is the single strongest independent predictor of early UCL reconstruction (aOR 1.19 per mph; p=.03) [7]. High showcase volume is independently associated with earlier reconstruction and significantly worse long-term professional career outcomes that persist after controlling for confounders [8].
3. Adolescent UCL tears are predominantly partial in morphology and should be managed conservatively as the initial treatment approach. A minimum 3-to-6-month trial of activity modification, flexor-pronator rehabilitation and PRP injection is warranted before surgical reconstruction is recommended in patients with Grade I or Grade II partial tears. This strategy supported by a 74% nonoperative return-to-play rate at mean 12 weeks and the finding that humeral-sided high-grade partial tears are the single most common tear subtype in adolescent pitchers [11,16].
4. When UCL reconstruction becomes necessary, the docking technique is safe and effective in skeletally immature adolescent pitchers achieving 84% return-to-play without physeal complications [14]. However, early-career reconstruction at age 19 or younger carries significantly longer recovery (19.8 versus 15.4 months; p=.023). Measurable long-term career consequences that must be incorporated explicitly into shared decision-making conversations with patients and families rather than minimized or omitted [8].
5. The single highest-priority evidence gap in this literature is a prospective randomized trial comparing UCL repair with internal brace augmentation versus formal reconstruction specifically in adolescent pitchers with complete UCL tears. This should be able to detect meaningful differences in recovery duration, return-to-play rate and long-term career outcomes, and the conduct of this trial should be regarded as the foremost research priority in adolescent baseball medicine.

References

1. Solomito MJ, Kostyun RO, Sabitsky JT, et al. Trends in ulnar collateral ligament injuries and surgery from 2010 to 2019: an analysis of a national medical claims database. Orthop J Sports Med 12 (2024): 23259671241290532.
2. Labatt JR, Aibinder WR, Dines JS, et al. Understanding the medial ulnar collateral ligament of the elbow: review of native ligament anatomy and function. World J Orthop 9 (2018): 78-84.
3. Olsen SJ, Fleisig GS, Dun S, et al. Risk factors for shoulder and elbow injuries in adolescent baseball pitchers. Am J Sports Med 34 (2006): 905-912.
4. Fleisig GS, Andrews JR. Prevention of elbow injuries in youth baseball pitchers. Sports Health 4 (2012): 419-424.
5. Erickson BJ, Nwachukwu BU, Rosas S, et al. Trends in medial ulnar collateral ligament reconstruction in the United States: a retrospective review of a large private-payer database from 2007 to 2011. Am J Sports Med 43 (2015): 1770-1774.
6. Camp CL, Conte S, D'Angelo J, et al. Epidemiology of ulnar collateral ligament reconstruction in Major and Minor League Baseball pitchers: comprehensive report of 1429 cases. J Shoulder Elbow Surg 27 (2018): 871-878.
7. Kriz PK, Staffa SJ, Kriz JP, et al. Ulnar collateral ligament tear in elite baseball pitchers: are high school showcase exposures associated with injury? Am J Sports Med 50 (2022): 3073-3082.
8. Kriz JP, DeFroda S, Staffa SJ, et al. Effect of high school showcase exposures and timing of ulnar collateral ligament tear on professional baseball careers in elite pitchers. Am J Sports Med 51 (2023): 344-353.
9. Lyman S, Fleisig GS, Andrews JR, et al. Effect of pitch type, pitch count, and pitching mechanics on risk of elbow and shoulder pain in youth baseball pitchers. Am J Sports Med 30 (2002): 463-468.
10. Fleisig GS, Andrews JR, Cutter GR, et al. Risk of serious injury for young baseball pitchers: a 10-year prospective study. Am J Sports Med 39 (2011): 253-257.
11. Goodrich E, Cox B, Plummer HA, et al. Adolescent baseball pitchers with ulnar collateral ligament tears exhibit a high proportion of partial tears. Am J Sports Med 50 (2022): 2198-2202.
12. Cain EL, Andrews JR, Dugas JR, et al. Outcome of ulnar collateral ligament reconstruction of the elbow in 1281 athletes: results in 743 athletes with minimum 2-year follow-up. Am J Sports Med 38 (2010): 2426-2434.
13. Carr JB, Wilson L, Sullivan SW, et al. Seasonal and monthly trends in elbow ulnar collateral ligament injuries and surgeries: a national epidemiological study. JSES Rev Rep Tech 2 (2021): 107-112.
14. Dines JS, Williams PN, ElAttrache N, et al. Ulnar collateral ligament reconstruction in the adolescent baseball player. J Shoulder Elbow Surg 25 (2016): 223-227.
15. Savoie FH, Trenhaile SW, Roberts J, et al. Primary repair of ulnar collateral ligament injuries of the elbow in young athletes. Am J Sports Med 36 (2008): 1066-1072.
16. Marshall NE, Keller RA, Van Holsbeeck M, et al. Surgical demand and return to sport after platelet-rich plasma injection for the treatment of partial UCL tears in high-level throwing athletes. Sports Med Arthrosc 23 (2015): 190-195.
17. Vitale MA, Ahmad CS. The outcome of elbow ulnar collateral ligament reconstruction in overhead athletes: a systematic review. Am J Sports Med 36 (2008): 1193-1205.
18. Zaremski JL, Zeppieri G Jr, Tripp BL. Sport specialization and overuse injuries in adolescent throwing athletes: a narrative review. J Athl Train 53 (2018): 1030-1039.
19. Ahmad CS, Grantham WJ, Greiwe RM. Public perceptions of Tommy John surgery. Phys Sportsmed 40 (2012): 64-72.
20. Zaremski JL, Horodyski M, Donlan RM, et al. Does geographic location matter on the prevalence of ulnar collateral ligament reconstruction in collegiate baseball pitchers? Orthop J Sports Med 3 (2015): 2325967115616582.
21. Lawton CD, Lamplot JD, Wright-Chisem JI, et al. State of the union on ulnar collateral ligament reconstruction in 2020: indications, techniques, and outcomes. Curr Rev Musculoskelet Med 13 (2020): 338-348.
22. Jones KJ, Dines JS, Rebolledo BJ, et al. Operative management of UCL injuries: indications and outcomes. Sports Health 4 (2012): 421-426.
23. Lane GC, Hymel AM, Bowman EN. Perceptions of ulnar collateral ligament injury in the online baseball community. JSES Rev Rep Tech 5 (2025): 182-185.